Palo Alto, CA, United States of America

YuHua Ji


 

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: YuHua Ji: Innovator in Pharmaceutical Compounds

Introduction

YuHua Ji is a prominent inventor based in Palo Alto, California, known for her significant contributions to the field of pharmaceuticals. With a total of 13 patents to her name, she has made remarkable advancements in the development of compounds that target various medical conditions.

Latest Patents

One of her latest inventions is related to biphenyl compounds that serve as muscarinic receptor antagonists. This invention provides compounds of formula I, which are designed to treat pulmonary disorders. The pharmaceutical compositions containing these compounds, along with the processes and intermediates for their preparation, showcase her innovative approach to addressing health issues. Another notable patent involves prodrugs of fencamfamine, which includes pharmaceutical compositions for targeted therapeutic applications and methods for synthesizing these compositions.

Career Highlights

Throughout her career, YuHua Ji has worked with notable companies such as Theravance Biopharma R&D IP, LLC and Praxis Bioresearch, LLC. Her work in these organizations has contributed to the advancement of pharmaceutical research and development.

Collaborations

YuHua Ji has collaborated with esteemed colleagues, including YongQi Mu and Craig Husfeld, further enhancing her innovative efforts in the pharmaceutical industry.

Conclusion

YuHua Ji's contributions to pharmaceutical innovations through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to impact the development of new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…